Triflusal vs Aspirin for the Prevention of Infarction: Randomized Stroke Study "TAPIRSS"


Phase 3 Results


There was no significant difference in the aggregate analysis of primary outcomes between the trifusal group and the aspirin group. There was, however, a significant difference in favor of trifusal (p = 0.038) in the aggregate analysis of secondary outcomes. This was due to a reduced incidence of hemorrhagic events in the trifusal group.